capsaicin 0.25 MG/ML / menthol 60 MG/ML / methyl salicylate 250 MG/ML Topical Solution

RxCUI
1989491
RxNorm name
capsaicin 0.25 MG/ML / menthol 60 MG/ML / methyl salicylate 250 MG/ML Topical Solution
Display name
Capsaicin/Menthol/Methyl salicylate (Topical)
Full name
capsaicin 0.25 MG/ML / menthol 60 MG/ML / methyl salicylate 250 MG/ML Topical Solution
Term type
SCD
Status
Active
Strength
0.025-6-25%
Dose form
Sol
Route
Topical
Updated
2026-11-02 22:18:05

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122017
Active start
122017
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
capsaicin0.25 MG / 1 MLcapsaicincapsaicin
methyl salicylate250 MG / 1 MLmethyl salicylatemethyl salicylate
menthol60 MG / 1 MLmentholmenthol

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Solution316986

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
capsaicin1992
methyl salicylate29787
menthol6750

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
70859002803rxnav_ndcsyes
70859002804rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6492c511-c483-c337-e053-2a91aa0a3916capsaicin 0.025 % / menthol 6 % / methyl salicylate 25 % Topical Solution [PSN] · capsaicin 0.25 MG/ML / menthol 60 MG/ML / methyl salicylate 250 MG/ML Topical Solution [SCD] · capsaicin 0.025 % / menthol 6 % / methyl salicylate 25 % Topical Solution [SY]32NuDroxicin pain relief Roll-On20180206

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
673b54ec-a6b2-4236-e053-2a91aa0aec86NuDroxIPAK I-800 pain relief PAK These highlights do not include all the information needed to use Meloxicam Tablets USP. safely and effectively. See full prescribing information for Meloxicam Tablets USP. Meloxicam Tablets USP, for oral use Initial U.S. Approval: 2000NuCare Pharmaceuticals,Inc.20240611
64bc6acc-58bf-0881-e053-2a91aa0a35e4NuDroxiPAK Pain Relief PAK These highlights do not include all the information needed to use CELECOXIB CAPSULES. See full prescribing information for CELECOXIB CAPSULES. CELECOXIB capsules, for oral use Initial U.S. Approval: 1998NuCare Pharmaceuticals,Inc.20210728
678f5379-b080-392c-e053-2991aa0a0abfNuDroxiPAK E-400 These highlights do not include all the information needed to use NuDroxiPAK E-400, see full prescribing information for NuDroxiPAK E-400. Initial U.S. ApprovalNuCare Pharmaceuticals,Inc.20210507
71d9d7c6-063a-6654-e053-2a95a90aa7feThese highlights do not include all the information needed to use Diclofenac Sod DR . See full prescribing information for Diclofenac Sod DR . Initial U.S. Approval 40-9184 Revised – October 2017 Rx Only Prescribing InformationNuCare Pharmaceuticals,Inc.20210507
67621cf4-e701-66e2-e053-2a91aa0ae8f0NuDroxiPAK M-15 These highlights do not include all the information needed to use Meloxicam Tablets USP. safely and effectively. See full prescribing information for Meloxicam Tablets USP. Meloxicam Tablets USP, for oral use Initial U.S. Approval: 2000NuCare Pharmceuticals,Inc.20210504
673d6a97-463d-6645-e053-2a91aa0a1435NuDroxiPak DSDR-50 These highlights do not include all the information needed to use Diclofenac Sod Tablets USP. Safely and effectively. See full prescribing information for use Diclofenac Sod Tablets USP. Initial U.S. ApprovalNuCare Pharmaceuticals, Inc.20210504
678aad78-a2b7-f7c9-e053-2a91aa0a4f26NuDroxiPAK DSDR-75 These highlights do not include all the information needed to use Diclofenac Sod DR . See full prescribing information for Diclofenac Sod DR . Initial U.S. ApprovalNuCare Pharmaceuticals,Inc. | NuCare Pharmceuticals,Inc.20210504
67903a9b-b94e-1f65-e053-2991aa0a0e43NuDroxiPAK N-500 These highlights do not include all the information needed to use NuDroxiPAK N-500. See full prescribing information for NuDroxiPAK N-500. Initial U.S. ApprovalNuCare Pharmaceuticals,Inc.20210504
7099d4b1-6893-234a-e053-2991aa0a682bThese highlights do not include all the information needed to use Diclofenac Sodium Topical Solution safely and effectively. See full prescribing information for Diclofenac Sodium Topical Solution.DICLOFENAC Sodium Topical Solution 1.5% w/w is for topical use only. Initial U.S. Approval: 1988Nucare Pharmaceuticals Inc | NuCare Pharmaceuticals,Inc.20210504
6492c511-c483-c337-e053-2a91aa0a3916NuDroxicin pain relief Roll-OnNuCare Pharmaceuticals Inc20180206
87d5ff9e-c67d-4395-827c-fe6bad7a1059NuDroxicin pain relief Roll-OnNuCare Pharmaceuticals Inc20171120

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCM02ABCapsaicin and similar agentsATC1-4capsaicin
ATCN01BXOther local anestheticsATC1-4capsaicin
MEDRTD002211CapsaicinCHEMhas_ingredientcapsaicin
MEDRTD008610MentholCHEMhas_ingredientmenthol
MEDRTD012459SalicylatesCHEMhas_ingredientmethyl salicylate
MEDRTD059787Acute PainDISEASEmay_treatmethyl salicylate
MEDRTD001168ArthritisDISEASEmay_treatmethyl salicylate
MEDRTD001416Back PainDISEASEmay_treatmethyl salicylate
MEDRTD003288ContusionsDISEASEmay_treatmethyl salicylate
MEDRTD003929Diabetic NeuropathiesDISEASEmay_treatcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withmenthol
MEDRTD004342Drug HypersensitivityDISEASEci_withmethyl salicylate
MEDRTD006562Herpes ZosterDISEASEmay_treatcapsaicin
MEDRTD007249InflammationDISEASEmay_treatmethyl salicylate
MEDRTD009120Muscle CrampDISEASEmay_treatmethyl salicylate
MEDRTD009437NeuralgiaDISEASEmay_treatcapsaicin
MEDRTD010146PainDISEASEmay_preventcapsaicin
MEDRTD010146PainDISEASEmay_treatmenthol
MEDRTD012871Skin DiseasesDISEASEmay_treatmenthol
MEDRTD013180Sprains and StrainsDISEASEmay_treatmethyl salicylate
MEDRTN0000000069Calcium Channel AntagonistsMOAhas_moamenthol
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moamethyl salicylate
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moacapsaicin
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moamethyl salicylate
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_pemethyl salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pecapsaicin
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pementhol
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_pemethyl salicylate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.25 MG/ML / 60 MG/ML / 250 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymcapsaicin 0.025 % / menthol 6 % / methyl salicylate 25 % Topical Solution
SOURCESSourceMicromedex RED BOOK
SOURCESSourceNational Drug Data File Plus Source Vocabulary